Arnold, Natalie
Koenig, Wolfgang
Funding for this research was provided by:
Technische Universität München
Article History
Accepted: 25 October 2023
First Online: 28 November 2023
Declarations
:
: N.A. reports receiving consulting fees and grant support from Novartis. W.K. reports receiving consulting fees and lecture fees from AstraZeneca, Novartis, and Amgen; consulting fees from Pfizer, The Medicines Company, DalCor Pharmaceuticals, Kowa, Corvidia Therapeutics, Esperion, Genentech, OMEICOS, Novo Nordisk, LIB Therapeutics, TenSixteen Bio, New Amsterdam Pharma and Daiichi Sankyo; lecture fees from Berlin-Chemie, Bristol-Myers Squibb, and Sanofi; and grant support and provision of reagents from Singulex, Abbott, Roche Diagnostics, and Dr Beckmann Pharma. W.K. has been a member of the executive steering committees of JUPITER, CANTOS, SPIRE, GLAGOV, COLCOT and ORION.
: This article does not contain any studies with human or animal subjects performed by any of the authors.